Nasdaq
MREO
Mereo BioPharma Group plc
- Health Care
- United Kingdom
- 1 day
- +0.8%
- 1 month
- −8.6%
- 1 year
- −80.8%
$0.3059 · Mkt cap $47.5M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Mereo BioPharma Group plc
$0.3059 · Mkt cap $47.5M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Mereo BioPharma Group plc trades under the ticker MREO on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $47.5M. The last closing price was $0.3059, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −80.8%, and −8.6% over the past month. Returns are price returns and exclude dividends.
This page exists because MREO is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.